BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 22822098)

  • 1. Functional study of risk loci of stem cell-associated gene lin-28B and associations with disease survival outcomes in epithelial ovarian cancer.
    Lu L; Katsaros D; Mayne ST; Risch HA; Benedetto C; Canuto EM; Yu H
    Carcinogenesis; 2012 Nov; 33(11):2119-25. PubMed ID: 22822098
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LIN-28B/let-7a/IGF-II axis molecular subtypes are associated with epithelial ovarian cancer prognosis.
    Lu L; Katsaros D; Canuto EM; Biglia N; Risch HA; Yu H
    Gynecol Oncol; 2016 Apr; 141(1):121-7. PubMed ID: 26751131
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integration of Population-Level Genotype Data with Functional Annotation Reveals Over-Representation of Long Noncoding RNAs at Ovarian Cancer Susceptibility Loci.
    Reid BM; Permuth JB; Chen YA; Teer JK; Monteiro AN; Chen Z; Tyrer J; Berchuck A; Chenevix-Trench G; Doherty JA; Goode EL; Iverson ES; Lawrenson K; Pearce CL; Pharoah PD; Phelan CM; Ramus SJ; Rossing MA; Schildkraut JM; Cheng JQ; Gayther SA; Sellers TA; ; ;
    Cancer Epidemiol Biomarkers Prev; 2017 Jan; 26(1):116-125. PubMed ID: 28035019
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ABCA transporter gene expression and poor outcome in epithelial ovarian cancer.
    Hedditch EL; Gao B; Russell AJ; Lu Y; Emmanuel C; Beesley J; Johnatty SE; Chen X; Harnett P; George J; ; Williams RT; Flemming C; Lambrechts D; Despierre E; Lambrechts S; Vergote I; Karlan B; Lester J; Orsulic S; Walsh C; Fasching P; Beckmann MW; Ekici AB; Hein A; Matsuo K; Hosono S; Nakanishi T; Yatabe Y; Pejovic T; Bean Y; Heitz F; Harter P; du Bois A; Schwaab I; Hogdall E; Kjaer SK; Jensen A; Hogdall C; Lundvall L; Engelholm SA; Brown B; Flanagan J; Metcalf MD; Siddiqui N; Sellers T; Fridley B; Cunningham J; Schildkraut J; Iversen E; Weber RP; Berchuck A; Goode E; Bowtell DD; Chenevix-Trench G; deFazio A; Norris MD; MacGregor S; Haber M; Henderson MJ
    J Natl Cancer Inst; 2014 Jul; 106(7):. PubMed ID: 24957074
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genome-wide Analysis Identifies Novel Loci Associated with Ovarian Cancer Outcomes: Findings from the Ovarian Cancer Association Consortium.
    Johnatty SE; Tyrer JP; Kar S; Beesley J; Lu Y; Gao B; Fasching PA; Hein A; Ekici AB; Beckmann MW; Lambrechts D; Van Nieuwenhuysen E; Vergote I; Lambrechts S; Rossing MA; Doherty JA; Chang-Claude J; Modugno F; Ness RB; Moysich KB; Levine DA; Kiemeney LA; Massuger LF; Gronwald J; Lubiński J; Jakubowska A; Cybulski C; Brinton L; Lissowska J; Wentzensen N; Song H; Rhenius V; Campbell I; Eccles D; Sieh W; Whittemore AS; McGuire V; Rothstein JH; Sutphen R; Anton-Culver H; Ziogas A; Gayther SA; Gentry-Maharaj A; Menon U; Ramus SJ; Pearce CL; Pike MC; Stram DO; Wu AH; Kupryjanczyk J; Dansonka-Mieszkowska A; Rzepecka IK; Spiewankiewicz B; Goodman MT; Wilkens LR; Carney ME; Thompson PJ; Heitz F; du Bois A; Schwaab I; Harter P; Pisterer J; Hillemanns P; ; Karlan BY; Walsh C; Lester J; Orsulic S; Winham SJ; Earp M; Larson MC; Fogarty ZC; Høgdall E; Jensen A; Kjaer SK; Fridley BL; Cunningham JM; Vierkant RA; Schildkraut JM; Iversen ES; Terry KL; Cramer DW; Bandera EV; Orlow I; Pejovic T; Bean Y; Høgdall C; Lundvall L; McNeish I; Paul J; Carty K; Siddiqui N; Glasspool R; Sellers T; Kennedy C; Chiew YE; Berchuck A; MacGregor S; Pharoah PD; Goode EL; deFazio A; Webb PM; Chenevix-Trench G;
    Clin Cancer Res; 2015 Dec; 21(23):5264-76. PubMed ID: 26152742
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prediction value of intercellular adhesion molecule-1 gene polymorphisms for epithelial ovarian cancer risk, clinical features, and prognosis.
    Cai G; Ma X; Zou W; Huang Y; Zhang J; Wang D; Chen B
    Gene; 2014 Aug; 546(1):117-23. PubMed ID: 23933413
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An insulin-like growth factor-II intronic variant affects local DNA conformation and ovarian cancer survival.
    Lu L; Risch E; Deng Q; Biglia N; Picardo E; Katsaros D; Yu H
    Carcinogenesis; 2013 Sep; 34(9):2024-30. PubMed ID: 23677070
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Upregulation of Abelson interactor protein 1 predicts tumor progression and poor outcome in epithelial ovarian cancer.
    Zhang J; Tang L; Chen Y; Duan Z; Xiao L; Li W; Liu X; Shen L
    Hum Pathol; 2015 Sep; 46(9):1331-40. PubMed ID: 26193797
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Promoter Hypermethylation of FANCF and Susceptibility and Prognosis of Epithelial Ovarian Cancer.
    Ding JJ; Wang G; Shi WX; Zhou HH; Zhao EF
    Reprod Sci; 2016 Jan; 23(1):24-30. PubMed ID: 26507869
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stomatin-like protein 2 is overexpressed in epithelial ovarian cancer and predicts poor patient survival.
    Sun F; Ding W; He JH; Wang XJ; Ma ZB; Li YF
    BMC Cancer; 2015 Oct; 15():746. PubMed ID: 26487491
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Common variants at the CHEK2 gene locus and risk of epithelial ovarian cancer.
    Lawrenson K; Iversen ES; Tyrer J; Weber RP; Concannon P; Hazelett DJ; Li Q; Marks JR; Berchuck A; Lee JM; Aben KK; Anton-Culver H; Antonenkova N; ; ; Bandera EV; Bean Y; Beckmann MW; Bisogna M; Bjorge L; Bogdanova N; Brinton LA; Brooks-Wilson A; Bruinsma F; Butzow R; Campbell IG; Carty K; Chang-Claude J; Chenevix-Trench G; Chen A; Chen Z; Cook LS; Cramer DW; Cunningham JM; Cybulski C; Plisiecka-Halasa J; Dennis J; Dicks E; Doherty JA; Dörk T; du Bois A; Eccles D; Easton DT; Edwards RP; Eilber U; Ekici AB; Fasching PA; Fridley BL; Gao YT; Gentry-Maharaj A; Giles GG; Glasspool R; Goode EL; Goodman MT; Gronwald J; Harter P; Hasmad HN; Hein A; Heitz F; Hildebrandt MA; Hillemanns P; Hogdall E; Hogdall C; Hosono S; Jakubowska A; Paul J; Jensen A; Karlan BY; Kjaer SK; Kelemen LE; Kellar M; Kelley JL; Kiemeney LA; Krakstad C; Lambrechts D; Lambrechts S; Le ND; Lee AW; Cannioto R; Leminen A; Lester J; Levine DA; Liang D; Lissowska J; Lu K; Lubinski J; Lundvall L; Massuger LF; Matsuo K; McGuire V; McLaughlin JR; Nevanlinna H; McNeish I; Menon U; Modugno F; Moysich KB; Narod SA; Nedergaard L; Ness RB; Noor Azmi MA; Odunsi K; Olson SH; Orlow I; Orsulic S; Pearce CL; Pejovic T; Pelttari LM; Permuth-Wey J; Phelan CM; Pike MC; Poole EM; Ramus SJ; Risch HA; Rosen B; Rossing MA; Rothstein JH; Rudolph A; Runnebaum IB; Rzepecka IK; Salvesen HB; Budzilowska A; Sellers TA; Shu XO; Shvetsov YB; Siddiqui N; Sieh W; Song H; Southey MC; Sucheston L; Tangen IL; Teo SH; Terry KL; Thompson PJ; Timorek A; Tworoger SS; Van Nieuwenhuysen E; Vergote I; Vierkant RA; Wang-Gohrke S; Walsh C; Wentzensen N; Whittemore AS; Wicklund KG; Wilkens LR; Woo YL; Wu X; Wu AH; Yang H; Zheng W; Ziogas A; Coetzee GA; Freedman ML; Monteiro AN; Moes-Sosnowska J; Kupryjanczyk J; Pharoah PD; Gayther SA; Schildkraut JM
    Carcinogenesis; 2015 Nov; 36(11):1341-53. PubMed ID: 26424751
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modelling genetic and clinical heterogeneity in epithelial ovarian cancers.
    Lawrenson K; Sproul D; Grun B; Notaridou M; Benjamin E; Jacobs IJ; Dafou D; Sims AH; Gayther SA
    Carcinogenesis; 2011 Oct; 32(10):1540-9. PubMed ID: 21859834
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FOXM1 expression is significantly associated with chemotherapy resistance and adverse prognosis in non-serous epithelial ovarian cancer patients.
    Tassi RA; Todeschini P; Siegel ER; Calza S; Cappella P; Ardighieri L; Cadei M; Bugatti M; Romani C; Bandiera E; Zanotti L; Tassone L; Guarino D; Santonocito C; Capoluongo ED; Beltrame L; Erba E; Marchini S; D'Incalci M; Donzelli C; Santin AD; Pecorelli S; Sartori E; Bignotti E; Odicino F; Ravaggi A
    J Exp Clin Cancer Res; 2017 May; 36(1):63. PubMed ID: 28482906
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of the RNA-binding proteins Lin28B and IGF2BP3 (IMP3) is associated with chemoresistance and poor disease outcome in ovarian cancer.
    Hsu KF; Shen MR; Huang YF; Cheng YM; Lin SH; Chow NH; Cheng SW; Chou CY; Ho CL
    Br J Cancer; 2015 Jul; 113(3):414-24. PubMed ID: 26158423
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A functional variant in HOXA11-AS, a novel long non-coding RNA, inhibits the oncogenic phenotype of epithelial ovarian cancer.
    Richards EJ; Permuth-Wey J; Li Y; Chen YA; Coppola D; Reid BM; Lin HY; Teer JK; Berchuck A; Birrer MJ; Lawrenson K; Monteiro AN; Schildkraut JM; Goode EL; Gayther SA; Sellers TA; Cheng JQ
    Oncotarget; 2015 Oct; 6(33):34745-57. PubMed ID: 26430965
    [TBL] [Abstract][Full Text] [Related]  

  • 16. VEGF gene polymorphisms and outcome of epithelial ovarian cancer patients.
    Camerin GR; Brito AB; Vassallo J; Derchain SF; Lima CS
    Future Oncol; 2017 Feb; 13(5):409-414. PubMed ID: 27780361
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Germline polymorphisms in an enhancer of PSIP1 are associated with progression-free survival in epithelial ovarian cancer.
    French JD; Johnatty SE; Lu Y; Beesley J; Gao B; Kalimutho M; Henderson MJ; Russell AJ; Kar S; Chen X; Hillman KM; Kaufmann S; Sivakumaran H; O'Reilly M; Wang C; Korbie DJ; ; ; Lambrechts D; Despierre E; Van Nieuwenhuysen E; Lambrechts S; Vergote I; Karlan B; Lester J; Orsulic S; Walsh C; Fasching PA; Beckmann MW; Ekici AB; Hein A; Matsuo K; Hosono S; Pisterer J; Hillemanns P; Nakanishi T; Yatabe Y; Goodman MT; Lurie G; Matsuno RK; Thompson PJ; Pejovic T; Bean Y; Heitz F; Harter P; du Bois A; Schwaab I; Hogdall E; Kjaer SK; Jensen A; Hogdall C; Lundvall L; Engelholm SA; Brown B; Flanagan JM; Metcalf MD; Siddiqui N; Sellers T; Fridley B; Cunningham J; Schildkraut JM; Iversen E; Weber RP; Brennan D; Berchuck A; Pharoah P; Harnett P; Norris MD; Haber M; Goode EL; Lee JS; Khanna KK; Meyer KB; Chenevix-Trench G; deFazio A; Edwards SL; MacGregor S;
    Oncotarget; 2016 Feb; 7(6):6353-68. PubMed ID: 26840454
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Single nucleotide polymorphisms in the D-loop region of mitochondrial DNA are associated with epithelial ovarian cancer prognosis.
    Kong D; Shi S; Li Y
    Mitochondrial DNA; 2015; 26(6):848-50. PubMed ID: 24409896
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Misregulation of polo-like protein kinase 1, P53 and P21WAF1 in epithelial ovarian cancer suggests poor prognosis.
    Zhang R; Shi H; Ren F; Liu H; Zhang M; Deng Y; Li X
    Oncol Rep; 2015 Mar; 33(3):1235-42. PubMed ID: 25592872
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Specific point mutations in key redox enzymes are associated with chemoresistance in epithelial ovarian cancer.
    Fletcher NM; Belotte J; Saed MG; Memaj I; Diamond MP; Morris RT; Saed GM
    Free Radic Biol Med; 2017 Jan; 102():122-132. PubMed ID: 27890641
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.